Tvardi Therapeutics
Organisation
Trials
Phase 1, Terminated, 6 people, 20 May 2022
Named in competing interests
Telomerase reverse transcriptase as a core regulator of brain health
Consulting or advice, Founder, 11 Sept 2026
TERT activation targets DNA methylation and multiple aging hallmarks
Consulting or advice, Founder, Board or leadership role, 21 Jun 2024
Sources: pubmed.ncbi.nlm.nih.gov